SYRE R&D to Revenue
Spyre Therapeutics Inc · R&D to Revenue
SYRE R&D to Revenue
Latest reported0.00%period ending
SYRE Quarterly R&D/Revenue (0.00% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
SYRE r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 49.327% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 2,527.0349% | |
| 6,957.5758% | |
| 8,482.7381% | |
| 6,883.3333% | |
| 2,459.68% | |
| 1,246.5492% | |
| 460.5379% | |
| 1,061.6869% | |
| 99.1457% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 383.5997% | |
| 454.9669% | |
| 390.7557% | |
| 494.7661% | |
| 394.5233% | |
| 503.9715% | |
| 380.1925% | |
| 468.6684% | |
| 321.9228% | |
| 418.6263% | |
| 250.2208% | |
| 291.6123% | |
| 79.8366% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |